Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. prepares improved inhibitors of protein farnesyltransferase

June 17, 1997

GABArho receptor antagonists described by University of California

June 17, 1997

La Jolla Cancer Res. Found. discloses integrin-binding peptides

June 17, 1997

Chiral TNF inhibitors reported by Schering AG

June 11, 1997

Merck & Co. continues to develop 5alpha-reductase inhibitors

June 11, 1997

Thomae prepares fibrinogen receptor antagonists

June 11, 1997

Novel fibrinogen antagonist from Merck & Co.

June 11, 1997

Janssen prepares lubelozole N-oxides

June 10, 1997

P&U discloses inhibitors of enzyme involved in neurodegenerative diseases

June 10, 1997

Thrombin inhibitors revealed by Merck & Co.

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...